174 related articles for article (PubMed ID: 31587337)
1. Risk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study.
Orzel LA; Abel EE; Blais DM; Wang TF; Porter KA; Burcham PK
Pharmacotherapy; 2019 Dec; 39(12):1157-1166. PubMed ID: 31587337
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
Tsu LV; Dager WE
Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
[TBL] [Abstract][Full Text] [Related]
3. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
[TBL] [Abstract][Full Text] [Related]
4. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
Kiser TH; Burch JC; Klem PM; Hassell KL
Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
Dangas GD; Lefèvre T; Kupatt C; Tchetche D; Schäfer U; Dumonteil N; Webb JG; Colombo A; Windecker S; Ten Berg JM; Hildick-Smith D; Mehran R; Boekstegers P; Linke A; Tron C; Van Belle E; Asgar AW; Fach A; Jeger R; Sardella G; Hink HU; Husser O; Grube E; Deliargyris EN; Lechthaler I; Bernstein D; Wijngaard P; Anthopoulos P; Hengstenberg C;
J Am Coll Cardiol; 2015 Dec; 66(25):2860-2868. PubMed ID: 26477635
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Bain J; Meyer A
Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
[TBL] [Abstract][Full Text] [Related]
8. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
Kiser TH; Fish DN
Pharmacotherapy; 2006 Apr; 26(4):452-60. PubMed ID: 16553502
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
12. Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia.
Burcham PK; Abel EE; Gerlach AT; Murphy CV; Belcher M; Blais DM
Am J Health Syst Pharm; 2013 Jun; 70(11):980-7. PubMed ID: 23686604
[TBL] [Abstract][Full Text] [Related]
13. UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.
O'Brien SH; Yee DL; Lira J; Goldenberg NA; Young G
J Thromb Haemost; 2015 Sep; 13(9):1615-22. PubMed ID: 26180006
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.
Tsu LV; Dager WE
Pharmacotherapy; 2012 Jan; 32(1):20-6. PubMed ID: 22392825
[TBL] [Abstract][Full Text] [Related]
15. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
16. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
[TBL] [Abstract][Full Text] [Related]
17. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
[TBL] [Abstract][Full Text] [Related]
18. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials.
Shah R; Rogers KC; Ahmed AJ; King BJ; Rao SV
JACC Cardiovasc Interv; 2016 Jul; 9(13):1313-20. PubMed ID: 27318846
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.
Zaleski KL; DiNardo JA; Nasr VG
Anesth Analg; 2019 Jan; 128(1):43-55. PubMed ID: 29461391
[TBL] [Abstract][Full Text] [Related]
20. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
